Linked Life Data

12164405

Source:http://linkedlifedata.com/resource/pubmed/id/12164405

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2002-8-7
pubmed:abstractText
To undertake post-marketing surveillance (PMS) of arteether (E-Mal) with the aim of obtaining feedback from clinicians regarding its safety, tolerability, efficacy and adverse event profile in patients of P. falciparum malaria.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0004-5772
pubmed:author
pubmed:issnType
Print
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
539-45
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Post-marketing surveillance of arteether in malaria.
pubmed:affiliation
Division of Clinical and Experimental Medicine, Central Drug Research Institute, Lucknow.
pubmed:publicationType
Journal Article, Clinical Trial, Clinical Trial, Phase IV